EUVIMEDEUVIMED entdecken
Open Access

A survey on polypharmacy and use of inappropriate medications

Sujit Rambhade, Anup Chakarborty, Anand Shrivastava, Umesh K Patil, Ashish Rambhade

Toxicology International · 2012 · 19 (1) · 68

DOI: 10.4103/0971-6580.94506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicology International, 2012. Verfasst von Sujit Rambhade und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Peoples Institute of Pharmacy & Research Center, Peoples Group, Bhopal, Madhya Pradesh, India. Die Arbeit wurde bisher 98-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the past, polypharmacy was referred to the mixing of many drugs in one prescription. Today polypharmacy implies to the prescription of too many medications for an individual patient, with an associated higher risk of adverse drug reactions (ADRs) and interactions. Situations certainly exist where the combination therapy or polytherapy is the used for single disease condition. Polypharmacy is a problem of substantial importance, in terms of both direct medication costs and indirect medication costs resulting from drug-related morbidity. Polypharmacy increases the risk of side effects and interactions. Moreover it is a preventable problem. A retrospective study was carried out at Bhopal district (Capital of Madhya Pradesh, India) in the year of September-November 2009 by collecting prescriptions of consultants at various levels of health care. The tendency of polypharmacy was studied and analyzed under the various heads in the survey. Available data suggests that polypharmacy is a widespread problem, and physician, clinical pharmacists and patients are all responsible. These risks can be minimized through identifying the prevalence of this potential problem in a high-risk population and by increasing awareness among patients and healthcare professionals. Physicians and clinical pharmacists have the potential to combating this problem through a variety of interventions such as reducing the number of medications taken, reducing the number of doses taken, increasing patient adherence, preventing ADRs, improving patient quality of life and decreasing facility and drug costs.

Schlagwörter

Stichwörter der Autor:innen

Adverse drug reactionsclinical surveyinappropriate medicationpolypharmacypreventions

Autor:innen und Institutionen

  • Department of Pharmacology, Peoples Institute of Pharmacy & Research Center, Peoples Group, Bhopal, Madhya Pradesh, India.

Zitieren

APA

Rambhade, S., Chakarborty, A., Shrivastava, A., Patil, U. K., & Rambhade, A. (2012). A survey on polypharmacy and use of inappropriate medications. Toxicology International, 19(1), 68. https://doi.org/10.4103/0971-6580.94506

Vancouver

Rambhade S, Chakarborty A, Shrivastava A, Patil UK, Rambhade A. A survey on polypharmacy and use of inappropriate medications. Toxicology International. 2012;19(1):68. doi:10.4103/0971-6580.94506

BibTeX
@article{Rambhade2012,
  author = {Rambhade, Sujit and Chakarborty, Anup and Shrivastava, Anand and Patil, Umesh K and Rambhade, Ashish},
  title = {A survey on polypharmacy and use of inappropriate medications},
  journal = {Toxicology International},
  year = {2012},
  volume = {19},
  number = {1},
  pages = {68},
  doi = {10.4103/0971-6580.94506}
}
Kostenlos starten →